Direkt zum Inhalt

Thomas, S. ; Schelker, R. ; Klobuch, S. ; Zaiss, S. ; Troppmann, M. ; Rehli, M. ; Haferlach, T. ; Herr, W. ; Reichle, A.

Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia

Article

Thomas, S. , Schelker, R., Klobuch, S., Zaiss, S., Troppmann, M., Rehli, M. , Haferlach, T., Herr, W. and Reichle, A. (2015) Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia. Haematologica 100 (1), e4-e6.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleHaematologica
PublisherFERRATA STORTI FOUNDATION
Place of PublicationPAVIA
Volume100
Number of Issue or Book Chapter1
Page Rangee4-e6
Date2015
Date of publication19 Dec 2024 07:51
InstitutionsMedicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Identification Number
ValueType
10.3324/haematol.2014.115055DOI
KeywordsPPAR-GAMMA; AZACITIDINE; DIFFERENTIATION; CHEMOTHERAPY; ALPHA; CELLS; biomodulatory therapy; acute myeloid leukemia; 5-azacytidine; ATRA; pioglitazone
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID60806

Export bibliographical data

Owner only: item control page

nach oben